Cytek Biosciences Inc

CTKB

Company Profile

  • Business description

    Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

  • Contact

    47215 Lakeview Boulevard
    FremontCA94538
    USA

    T: +1 877 922-9835

    https://www.cytekbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    688

Stocks News & Analysis

stocks

Have the 3 biggest losers of the ASX 200 fallen too far?

Finding value in some of the ASX’s worst recent performers.
stocks

Rethinking the way we invest in Aussie tech

Investing in Tech companies has many caveats from traditional investing. Let’s dive into how you can gauge the true profitability of a tech company.
stocks

Undervalued ASX listed payment provider

Strong start to the new fiscal year.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,866.4056.60-0.63%
CAC 408,097.0025.71-0.32%
DAX 4023,597.44239.35-1.00%
Dow JONES (US)47,486.35230.07-0.48%
FTSE 1009,702.5317.98-0.18%
HKSE26,033.26174.370.67%
NASDAQ23,280.9284.77-0.36%
Nikkei 22549,303.28950.63-1.89%
NZX 50 Index13,448.4940.66-0.30%
S&P 5006,828.0521.04-0.31%
S&P/ASX 2008,565.2048.90-0.57%
SSE Composite Index3,914.0125.410.65%

Market Movers